Environmental and Occupational Exposure: Chronic inhalation of inorganic and organic particulates, such as silica, asbestos, ...

Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterized by excessive fibrotic tissue ...

The outcomes of patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Alongside the global adoption of antifibrotic therapies, there is currently relentless research for biomarkers and ...

In idiopathic pulmonary fibrosis, higher risk of mortality and lung transplant is linked to small decreases in FVC% predicted and DLCO% predicted.

Explore new advancements in lung disease treatment, focusing on idiopathic pulmonary fibrosis and its innovative therapies.

Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...

Rein previously announced positive topline results from Cohort 2 (5 mg BID) of the Phase 1b clinical trial of LTI-03 in IPF, in which a positive trend was observed in seven out of eight biomarkers ...

People living with cystic fibrosis can now take a once-daily drug that will help them breathe easier all day long, thanks to ...